Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806607 · ClinicalTrials.gov registry record · NA
19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT04806607 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 42 participants.
The verdict
NCT04806607, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.
Interventions
- PROCEDURE 19G FNB
- PROCEDURE 22G FNB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-04-30 |
| Est. Completion | 2022-03-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04806607
The ClinicalTrials.gov registry entry for NCT04806607 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 19G FNB is the first listed.
NCT04806607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04806607 about?
NCT04806607 is a clinical study titled "19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)". To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.
What is the current status of trial NCT04806607?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-04-30. Estimated completion is 2022-03-16.
What interventions are being tested in trial NCT04806607?
The interventions under investigation include: 19G FNB (PROCEDURE), 22G FNB (PROCEDURE).
Who is sponsoring clinical trial NCT04806607?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.